Jun 20, 2017BlackThorn Therapeutics To Receive Up to $8 Million in NIH Blueprint Neurotherapeutics Network FundiSouth San Francisco, Calif. – June 20, 2017 – BlackThorn Therapeutics, a clinical-stage biopharmaceutical company discovering and...
Jun 20, 2017eFFECTOR Therapeutics to Collaborate with Pfizer and Merck KGaA, Darmstadt, Germany to Evaluate a NoSAN DIEGO, June 20, 2017 /PRNewswire/ -- eFFECTOR Therapeutics announced today it has entered into a clinical collaboration and supply...
Jun 7, 2017BlackThorn Therapeutics Announces Innovative Clinical Collaboration Agreement with Mindstrong HealthBLACKTHORN’S BTRX-246040 NOCICEPTIN PROGRAM IS FIRST MOLECULE AND CLINICAL PROGRAM TO INCORPORATE MINDSTRONG HEALTH’S PATENTED TECHNOLOGY...